HRP20150697T8 - Derivati azaindola kao inhibitori proteina kinaze abl i src - Google Patents

Derivati azaindola kao inhibitori proteina kinaze abl i src

Info

Publication number
HRP20150697T8
HRP20150697T8 HRP20150697TT HRP20150697T HRP20150697T8 HR P20150697 T8 HRP20150697 T8 HR P20150697T8 HR P20150697T T HRP20150697T T HR P20150697TT HR P20150697 T HRP20150697 T HR P20150697T HR P20150697 T8 HRP20150697 T8 HR P20150697T8
Authority
HR
Croatia
Prior art keywords
protein inhibitors
src protein
kinase abl
azaindol
derivatives
Prior art date
Application number
HRP20150697TT
Other languages
English (en)
Croatian (hr)
Inventor
Abdelaziz Yasri
Gwénaël CHEVE
Cédric BORIES
Louis Delon
Original Assignee
Oribase Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oribase Pharma filed Critical Oribase Pharma
Publication of HRP20150697T1 publication Critical patent/HRP20150697T1/hr
Publication of HRP20150697T8 publication Critical patent/HRP20150697T8/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HRP20150697TT 2009-02-12 2010-02-12 Derivati azaindola kao inhibitori proteina kinaze abl i src HRP20150697T8 (xx)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US20227909P 2009-02-12 2009-02-12
FR0900631A FR2941948B1 (fr) 2009-02-12 2009-02-12 Derives d'azaindoles en tant qu'inhibiteur des proteines kinases abl et src
EP10710439.0A EP2396325B1 (en) 2009-02-12 2010-02-12 Derivatives of azaindoles as inhibitors of protein kinases abl and src
PCT/IB2010/000593 WO2010092489A1 (en) 2009-02-12 2010-02-12 Derivatives of azaindoles as inhibitors of protein kinases abl and src

Publications (2)

Publication Number Publication Date
HRP20150697T1 HRP20150697T1 (hr) 2015-08-14
HRP20150697T8 true HRP20150697T8 (xx) 2015-11-06

Family

ID=40886859

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20150697TT HRP20150697T8 (xx) 2009-02-12 2010-02-12 Derivati azaindola kao inhibitori proteina kinaze abl i src

Country Status (15)

Country Link
US (1) US8580815B2 (enExample)
EP (1) EP2396325B1 (enExample)
JP (1) JP5583698B2 (enExample)
AU (1) AU2010212560B2 (enExample)
CA (1) CA2751478A1 (enExample)
DK (1) DK2396325T3 (enExample)
ES (1) ES2540962T3 (enExample)
FR (1) FR2941948B1 (enExample)
HR (1) HRP20150697T8 (enExample)
HU (1) HUE024989T2 (enExample)
PL (1) PL2396325T3 (enExample)
PT (1) PT2396325E (enExample)
SI (1) SI2396325T1 (enExample)
SM (1) SMT201500175B (enExample)
WO (1) WO2010092489A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ME03000B (me) * 2012-12-21 2018-10-20 Plexxikon Inc Jedinjenja i metode modulacije kinaze i povezane indikacije
FR3000493A1 (fr) * 2012-12-28 2014-07-04 Oribase Pharma Nouveaux inhibiteurs de proteines kinases
FR3000494B1 (fr) * 2012-12-28 2015-08-21 Oribase Pharma Nouveaux derives d'azaindoles en tant qu'inhibiteurs de proteines kinases
FR3000492B1 (fr) * 2012-12-28 2015-09-11 Oribase Pharma Nouveaux derives azaindole en tant qu'inhibiteurs multikinases
US10722484B2 (en) 2016-03-09 2020-07-28 K-Gen, Inc. Methods of cancer treatment
MA49014A (fr) * 2017-03-21 2020-02-05 Arbutus Biopharma Corp Dihydroindène-4-carboxamides substitués, leurs analogues et procédés d'utilisation correspondant
AU2021263383A1 (en) 2020-04-29 2022-11-24 Plexxikon Inc. Synthesis of heterocyclic compounds
CN111943947B (zh) * 2020-07-24 2021-04-30 重庆文理学院 1H-吡咯[2,3-b]吡啶衍生物及其合成方法与应用
CA3196620A1 (en) 2020-10-05 2022-04-14 Enliven Therapeutics, Inc. 5- and 6-azaindole compounds for inhibition of bcr-abl tyrosine kinases
WO2022076973A1 (en) * 2020-10-05 2022-04-14 Enliven Therapeutics, Inc. 7-azaindole compounds for inhibition of bcr-abl tyrosine kinases

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0330043D0 (en) * 2003-12-24 2004-01-28 Pharmacia Italia Spa Pyrrolo [2,3-b] pyridine derivatives active as kinase inhibitors process for their preparation and pharmaceutical compositions comprising them
GB0330042D0 (en) 2003-12-24 2004-01-28 Pharmacia Italia Spa Pyrrolo [2,3-b] pyridine derivatives active as kinase inhibitors process for their preparation and pharmaceutical compositions them
TW200616632A (en) * 2004-06-17 2006-06-01 Plexxikon Inc Compounds modulating c-kit activity and uses therefor
US7361764B2 (en) 2004-07-27 2008-04-22 Sgx Pharmaceuticals, Inc. Pyrrolo-pyridine kinase modulators
NZ553267A (en) 2004-07-27 2010-09-30 Sgx Pharmaceuticals Inc Pyrrolo-pyridine kinase modulators
US7709645B2 (en) 2004-07-27 2010-05-04 Sgx Pharmaceuticals, Inc. Pyrrolo-pyridine kinase modulators
WO2006104971A1 (en) * 2005-03-28 2006-10-05 Bristol-Myers Squibb Company Atp competitive kinase inhibitors
BRPI0716477A2 (pt) 2006-09-06 2014-03-18 Hoffmann La Roche Derivados heteroarila como inibidores de quinase protéica
JP5244118B2 (ja) * 2006-11-10 2013-07-24 ブリストル−マイヤーズ スクイブ カンパニー 新規キナーゼ阻害剤
WO2008144253A1 (en) * 2007-05-14 2008-11-27 Irm Llc Protein kinase inhibitors and methods for using thereof
WO2009111278A2 (en) * 2008-02-29 2009-09-11 Array Biopharma Inc. Raf inhibitor compounds and methods of use thereof
HUE035798T2 (en) * 2008-11-03 2018-05-28 Syntarga Bv CC-1065 analogues and conjugates

Also Published As

Publication number Publication date
US8580815B2 (en) 2013-11-12
ES2540962T3 (es) 2015-07-15
DK2396325T3 (en) 2015-06-29
EP2396325B1 (en) 2015-04-01
SI2396325T1 (sl) 2015-08-31
FR2941948A1 (fr) 2010-08-13
JP5583698B2 (ja) 2014-09-03
US20110312959A1 (en) 2011-12-22
PT2396325E (pt) 2015-08-21
AU2010212560B2 (en) 2016-01-21
FR2941948B1 (fr) 2013-04-05
WO2010092489A1 (en) 2010-08-19
HRP20150697T1 (hr) 2015-08-14
AU2010212560A1 (en) 2011-08-11
JP2012517465A (ja) 2012-08-02
SMT201500175B (it) 2015-09-07
EP2396325A1 (en) 2011-12-21
CA2751478A1 (en) 2010-08-19
PL2396325T3 (pl) 2015-10-30
HUE024989T2 (en) 2016-01-28

Similar Documents

Publication Publication Date Title
CY2019009I1 (el) Αναστολεις πρωτεϊνικων κινασων
HUS1900012I1 (hu) Vegyületek és készítmények protein-kináz inhibitorokként
IL280173A (en) Inhibitors of brutons tyrosine kinase
BRPI0910668A2 (pt) inibidores de proteína quinases
BRPI0716477A2 (pt) Derivados heteroarila como inibidores de quinase protéica
HRP20171534T8 (hr) Derivati fosfora kao inhibitori kinaza
BRPI0911228A2 (pt) compostos e composições como inibidores de proteínas quinase
EP2734205A4 (en) HETEROCYCLIC PROTEIN KINASE HEMMER
EP2632898A4 (en) HETEROCYCLIC TYROSINE KINASE HEMMER
BRPI0918846A2 (pt) inibidores de cinase heterocíclica
SMAP200800048A (it) Derivati pirimidinici utilizzati come inibitori dip13-chinasi
DE602007008837D1 (de) Als protein-kinase-inhibitoren nutzbare dyhydrodiazepine
BRPI0719797A2 (pt) compostos e composições como inibidores de proteína cinase
BRPI0719991A2 (pt) Derivados de di-hidropiridina úteis como inibidores de proteína cinase
HRP20141260T1 (xx) Spojevi i sastavi kao inhibitori kinaze proteina
CR10478A (es) Amino-piperidine derivatives as cetp inhibitors
HRP20150318T1 (xx) Derivati kinazolin-4(3h)-ona koji se upotrebljavaju kao inhibitori pi3 kinaze
SMT201400086B (it) Derivati chinazolin-4(3H)-one usati come inibitoridi PI3 chinasi
BRPI1009112A2 (pt) inibidores de tirosina quinase de bruton
ATE506358T1 (de) 2-benzylpyridazinonderivate als met-kinasehemmer
BR112012007300A2 (pt) derivador de pirimidina como inibidores proteína tirosina cinase 2
BR112012004448A2 (pt) "compostos e composições como inibidores de proteína cinase"
IL228311A0 (en) Protein kinase inhibitors
EP2515657A4 (en) Tyrosine kinase inhibitor
DK2358710T3 (da) AKT- og P70-S6-kinaseinhibitorer